ITMCTR2100005054尚未招募未知
Prospective, randomized, controlled, double-blind clinical study of traditional Chinese medicine combined with glucocorticoid in the treatment of generalized myasthenia gravis
Zhejiang Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. The first onset meets the diagnostic criteria for generalized myasthenia gravis;
- •2. Complete admission data, detailed condition description, complete disease course record and no obvious missing items;
- •3. Application of glucocorticoid therapy;
- •4. Aged over 18 years old;
- •5. The diagnosis of GMG was re-verified by at least two attending physicians or higher-level physicians based on typical clinical phenotypes and laboratory test results.
排除标准
- •1. Patients with other neuromuscular diseases or peripheral neuropathy;
- •2. Combined with serious cardiovascular and cerebrovascular, liver, kidney and hematopoietic system diseases, chronic severe infection, mental illness;
- •3. Pregnant or lactating women;
- •4. Those who use other immunosuppressants;
- •5. The application of traditional Chinese medicine including traditional Chinese medicine or acupuncture has been started before enrollment;
- •6. Those who have been enrolled in other clinical intervention studies and have conflicts with the observation of this topic;
- •7. Those who meet any of the above items will be excluded.
研究者
相似试验
进行中（未招募）
1 期
Controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgeryEUCTR2016-002162-30-BEFresenius Kabi Deutschland GmbH2,280
进行中（未招募）
1 期
Efficacy of nebulized 4.2% sodium-bicarbonate in COVID-19 pneumoniasevere COVID-19 pneumonia requires invasive ventillatory supportMedDRA version: 23.1Level: LLTClassification code 10084564Term: SARS-CoV-2 pneumoniaSystem Organ Class: 100000004862EUCTR2021-001665-20-HUSemmelweis University Department of Oralbiology200
已完成
不适用
Prospective, randomized, double-blind, controlled trial of the healing effect of Polaprezinc for NSAIDs induced small bowel injury.SAIDs-induced small bowel injuryJPRN-UMIN000001538Division of Gastroenterology,Department of Internal Medicine, Keio University40
已完成
不适用
Prospective, randomized, double-blind, controlled study for the incidence of small bowel mucosal injury caused by selective COX-2 inhibitor in healthy volunteersSmall bowel mucosal injuryJPRN-UMIN000003871Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University40
进行中（未招募）
1 期
Efficacy and Safety Evaluation for the Treatment of house dust mite induced allergic asthma and rhinitis/rhinoconjunctivitisEtiological treatment of mild to moderate controlled intermittent or persistent allergic asthma and intermittent or persistent allergic rhinitis / rhinoconjunctivitisMedDRA version: 20.0Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 21.1Level: LLTClassification code 10034382Term: Perennial allergic rhinitisSystem Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853MedDRA version: 21.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855EUCTR2021-003014-39-ESInmunotek, S.L.400